Effect of dietary Astaxanthin sources supplementation on muscle pigmentation and lipid peroxidation in rainbow trout (Oncorhynchus mykiss)

Astaxanthin is one of the major carotenoids in aquatic animals including salmonid fishes and is the preferred pigments added to salmon feed. It’s also a powerful antioxidant compared to other carotenoids and that may confer numerous health benefits. The aim of the present experi- ment was to investigate the effect of Astaxanthin deposition on the lipids peroxidation by studying the Malondialdeide (MDA) level in muscle of rainbow trout (Oncorhynchus mykiss). The Astaxanthin concentrations in fish fed with a commercial sources as Lucantin®Pink (BASF Ludwigshafen, Ger- many) reached values to 5.76±0.18x10-3 mg/g after 50 days feeding, while the MDA concentration de- creased from 1.56x103 to 0.45x103 ng/g. The correlation between MDA and Astaxanthin concentrations decreased linearly and confirmed the antioxidant properties of the pigment by reducing the lipids peroxidation

Pilot Projects

During the WISE project two industrial level wireless services were developed; an online trading system and a multiplayer interactive role game. The experience from these projects is the foundation of all the material presented in the previous chapters. This chapter briefly presents the case studies and how the guidelines presented in the previous chapters were applied in their development. For each project the process used, the technology, the architecture and a baseline of process and product measures are described. The sample projects are presented as a comprehensive example of how all the techniques and methods presented in the book fit together

Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014

BACKGROUND: Posthepatectomy liver failure is one of the most feared complications in extended hepatic resections. In 2012, a novel two-stage liver resection was developed, able to induce rapid and extensive hypertrophy by portal vein ligation and in situ liver splitting - Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS). The technique became more widely employed but its use remained controversial due to reporting of high complication and mortality rates. METHOD: A national audit was performed to gather information about the safety of the procedure and to better understand the complications. The audit was offered to all high-volume hepatobiliary centers in Italy. RESULTS: Of all Italian centers approached in January 2012, 12 centers with experience in ALPPS enrolled and participated in collection of data. Fifty patients underwent ALPPS between 2012 and 2014. In 48/50 patients completion of hepatectomy was performed successfully. Major morbidity occurred in 54% with a 20% 90-day mortality. Uni- and multivariate analysis showed that ALPPS for cholangiocarcinoma and a peak of bilirubin over 5 mg/dl between stages was associated with increase of 90-day mortality and worse survival. DISCUSSION: It is proposed that a moratorium be introduced for classic ALPPS in cholangiocarcinoma and to abort ALPPS in patients who develop an interstage increase in bilirubin, due to the high risk of liver failure and mortality

Risk Factors and Outcomes of Open Conversion During Minimally Invasive Major Hepatectomies: An International Multicenter Study on 3880 Procedures Comparing the Laparoscopic and Robotic Approaches

IntroductionDespite the advances in minimally invasive (MI) liver surgery, most major hepatectomies (MHs) continue to be performed by open surgery. This study aimed to evaluate the risk factors and outcomes of open conversion during MI MH, including the impact of the type of approach (laparoscopic vs. robotic) on the occurrence and outcomes of conversions.MethodsData on 3880 MI conventional and technical (right anterior and posterior sectionectomies) MHs were retrospectively collected. Risk factors and perioperative outcomes of open conversion were analyzed. Multivariate analysis, propensity score matching, and inverse probability treatment weighting analysis were performed to control for confounding factors.ResultsOverall, 3211 laparoscopic MHs (LMHs) and 669 robotic MHs (RMHs) were included, of which 399 (10.28%) had an open conversion. Multivariate analyses demonstrated that male sex, laparoscopic approach, cirrhosis, previous abdominal surgery, concomitant other surgery, American Society of Anesthesiologists (ASA) score 3/4, larger tumor size, conventional MH, and Institut Mutualiste Montsouris classification III procedures were associated with an increased risk of conversion. After matching, patients requiring open conversion had poorer outcomes compared with non-converted cases, as evidenced by the increased operation time, blood transfusion rate, blood loss, hospital stay, postoperative morbidity/major morbidity and 30/90-day mortality. Although RMH showed a decreased risk of conversion compared with LMH, converted RMH showed increased blood loss, blood transfusion rate, postoperative major morbidity and 30/90-day mortality compared with converted LMH.ConclusionsMultiple risk factors are associated with conversion. Converted cases, especially those due to intraoperative bleeding, have unfavorable outcomes. Robotic assistance seemed to increase the feasibility of the MI approach, but converted robotic procedures showed inferior outcomes compared with converted laparoscopic procedures